Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AddLife ABADDLF 88 5-Year Yield-on-Cost % is 1.02 as of Aug. 03, 2026, which is 40% above its 10-year median of 0.73. GuruFocus rates ADDLF with a GF Score™ of 88/100 and a GF Value™ of $15.15. The stock has 5 warning signs investors should review. Among 318 Medical Devices & Instruments companies, AddLife AB ranks worse than 77.04% on this metric.
AddLife AB's yield on cost for the quarter that ended in Jun. 2026 was 1.02.
The historical rank and industry rank for AddLife AB's 5-Year Yield-on-Cost % or its related term are showing as below:
ADDLF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.2 Med: 0.73 Max: 2.22
Current: 1.02
During the past 13 years, AddLife AB's highest Yield on Cost was 2.22. The lowest was 0.20. And the median was 0.73.
ADDLF's 5-Year Yield-on-Cost % is ranked worse than 77.04% of 318
companies
in the Medical Devices & Instruments industry
Industry Median: 2.435
vs ADDLF: 1.02
AddLife AB (OTCPK:ADDLF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
AddLife AB 5-Year Yield-on-Cost % Related Terms
ADDLF vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, AddLife AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where AddLife AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of AddLife AB is calculated as
AddLife AB (ADDLF) has a 5-Year Yield-on-Cost % of 1.02 as of Aug. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on AddLife AB and its competitors. This is 40% above median its historical median of 0.73. Over the past decade, AddLife AB's 5-Year Yield-on-Cost % has ranged from 0.20 to 2.22. According to the industry distribution chart, AddLife AB ranks #245 out of 318 companies in the Medical Devices & Instruments industry, placing it in the top 77%.
Is AddLife AB's 5-Year Yield-on-Cost % too high?
AddLife AB's current 5-Year Yield-on-Cost % of 1.02 is 40% above median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 2.22. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.44. AddLife AB's value of 1.02 is 58.1% below this industry median. Based on the distribution chart, AddLife AB ranks #245 out of 318 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, AddLife AB has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AddLife AB ranks #245 out of 318 companies for 5-Year Yield-on-Cost %. This places AddLife AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.44. AddLife AB's value of 1.02 is 58.1% below this benchmark. Historically, AddLife AB's own 5-Year Yield-on-Cost % has ranged from 0.20 to 2.22 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 2.44, AddLife AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.44, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AddLife AB's current 5-Year Yield-on-Cost % of 1.02 is 58.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on AddLife AB and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AddLife AB's current 5-Year Yield-on-Cost % is 1.02, which is 40% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
AddLife AB (ADDLF) has a current 5-Year Yield-on-Cost % of 1.02. The stock's GF Value™ is $15.15, compared to a current price of $15.75 — trading 4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.02, which is 40% above median its 10-year median of 0.73 and 58.1% below the Medical Devices & Instruments industry median of 2.44. AddLife AB's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For AddLife AB (ADDLF), the current 5-Year Yield-on-Cost % is 1.02 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AddLife AB (ADDLF) Overvalued in 2026?
Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued.
The current stock price of $15.75 is trading 4% above its estimated GF Value™ of $15.15.
Key valuation signals for ADDLF:
5-Year Yield-on-Cost %: 1.02 (40% above median its 10-year median of 0.73)
GF Value™: $15.15 vs. price of $15.75 (4% above fair value)
Industry Position: 58.1% below the Medical Devices & Instruments median (#245 of 318)
No single metric tells the full story. See the ADDLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
88GF Score
Get the complete analysis for ADDLF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADDLF has been successfully added to your 
